中年および高齢者の全因死亡率に対する視力障害と慢性腎疾患の併合効果:中国における縦断型集団研究

Hanyuan Ye¹, Ye He^2,3,4

¹Department of Ophthalmology, Jingmen People's Hospital, Jingmen, Hubei, China.

BMJ open

|September 3, 2025

まとめ

慢性腎臓病 (CKD) と視覚障害 (VI) は,成人における死亡リスクを増加させる. このリスクの組み合わせは70歳未満の人々にとって重要であり,統合された予防と治療戦略の必要性を強調しています.

科学分野:

ゲロントロジー
腎臓科
眼科について

背景:

視力障害 (VI) と慢性腎臓病 (CKD) は,死亡率の増加に関連する一般的な疾患です.
VIとCKDが死亡リスクに与える影響は,まだ十分に研究されていない.

研究の目的:

大規模な集団における全因死亡率に対するVIとCKDの独立した効果と組み合わせを調査する.

主な方法:

中国の健康と退職の長期研究 (CHARLS) のデータを利用した縦断型,人口ベースのコホート研究.
CKD と VI ステータスに基づいて4つのグループに分類された45歳以上のコミュニティに住む成人を含みます.
すべての原因による死亡率を分析するために,コックス比例リスク回帰を用いた.

主要な成果:

CKDとVIの両方の参加者は,最も高い死亡率 (19. 22%) を示しました.
慢性腎臓病とVIの併用は,いずれの症状もない患者と比較して,あらゆる原因による死亡率 (HR: 1. 174; 95% CI: 1. 555から 1. 293) を著しく増加させた.
この増加した死亡リスクは,70歳以上の参加者では有意ではなかった.

結論:

CKDはあらゆる原因による死亡率の重要な予測因子であり,VIは独立したリスク因子ではありません.
VIとCKDの組み合わせは,特に70歳未満の中年および高齢者の間では,早死のリスクが高まります.
死亡リスクを軽減するために,CKDとVIの両方の管理の重要性を強調しています.

キーワード:

熟成した中国腎臓と尿路の疾患死亡率眼科

さらに関連する動画

07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

6.0K

10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

3.6K

関連する概念動画

01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

01:17

Factors Affecting Renal Clearance: Renal Impairment

154

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

154

01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...

01:22

Photoreceptors and Visual Pathways

6.5K

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...